11-62338027-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001083926.2(ASRGL1):​c.50A>G​(p.Lys17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,608,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

ASRGL1
NM_001083926.2 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.10
Variant links:
Genes affected
ASRGL1 (HGNC:16448): (asparaginase and isoaspartyl peptidase 1) Enables asparaginase activity and beta-aspartyl-peptidase activity. Involved in asparagine catabolic process via L-aspartate. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.039159298).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ASRGL1NM_001083926.2 linkuse as main transcriptc.50A>G p.Lys17Arg missense_variant 2/7 ENST00000415229.6 NP_001077395.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ASRGL1ENST00000415229.6 linkuse as main transcriptc.50A>G p.Lys17Arg missense_variant 2/71 NM_001083926.2 ENSP00000400057 P1Q7L266-1
ENST00000400902.4 linkuse as main transcriptn.64T>C non_coding_transcript_exon_variant 1/24

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152218
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000127
AC:
3
AN:
236856
Hom.:
0
AF XY:
0.00000778
AC XY:
1
AN XY:
128598
show subpopulations
Gnomad AFR exome
AF:
0.000202
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000343
AC:
5
AN:
1455684
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
723616
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152336
Hom.:
0
Cov.:
34
AF XY:
0.0000805
AC XY:
6
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000289
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000989
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2024The c.50A>G (p.K17R) alteration is located in exon 2 (coding exon 1) of the ASRGL1 gene. This alteration results from a A to G substitution at nucleotide position 50, causing the lysine (K) at amino acid position 17 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 20, 2023This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 17 of the ASRGL1 protein (p.Lys17Arg). This variant is present in population databases (rs543873786, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ASRGL1-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
8.3
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.48
T;T;T;T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.14
.;T;T;T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.039
T;T;T;T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
0.94
L;L;.;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-1.2
N;N;.;.
REVEL
Benign
0.099
Sift
Benign
0.44
T;T;.;.
Sift4G
Benign
0.27
T;T;T;T
Polyphen
0.048
B;B;.;.
Vest4
0.085
MutPred
0.34
Loss of ubiquitination at K17 (P = 0.0218);Loss of ubiquitination at K17 (P = 0.0218);Loss of ubiquitination at K17 (P = 0.0218);Loss of ubiquitination at K17 (P = 0.0218);
MVP
0.62
MPC
0.34
ClinPred
0.056
T
GERP RS
1.9
Varity_R
0.23
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs543873786; hg19: chr11-62105499; API